Profile
Joseph P.
Macaluso served as the Chief Financial & Accounting Officer at Electro Catheter Corp.
from 2010 to 2011.
He also held the same position at Tel-Instrument Electronics Corp.
from 2010 to 2012.
Currently, he is the Chief Financial Officer at QXO, Inc. from 2021 to 2024.
Mr. Macaluso completed his undergraduate degree at Fairfield University.
Former positions of Joseph Macaluso
| Companies | Position | End |
|---|---|---|
| QXO, INC. | Director of Finance/CFO | 2024-06-05 |
| TEL-INSTRUMENT ELECTRONICS CORP. | Director of Finance/CFO | 2012-02-06 |
Electro Catheter Corp.
 Electro Catheter Corp. Medical SpecialtiesHealth Technology Electro-Catheter Corp. designs, develops, manufactures and markets products utilized in connection with illnesses of the heart and circulatory system and make use of catheters and related products. The company has targeted electrophysiology as its focal area for future growth, but intends to maintain and develop products for the emergency care, invasive and non-invasive cardiology and invasive radiology markets. The company also continues to explore opportunities to expand its Original Equipment Manufacturing business and contract research and development business to capitalize on its catheter technology expertise and its manufacturing capabilities. The Company was founded in 1961 and is headquartered in Rahway, NJ. | Director of Finance/CFO | 2011-01-09 |
Training of Joseph Macaluso
| Fairfield University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TEL-INSTRUMENT ELECTRONICS CORP. | Electronic Technology |
| QXO, INC. | Commercial Services |
| Private companies | 1 |
|---|---|
Electro Catheter Corp.
Electro Catheter Corp. Medical SpecialtiesHealth Technology Electro-Catheter Corp. designs, develops, manufactures and markets products utilized in connection with illnesses of the heart and circulatory system and make use of catheters and related products. The company has targeted electrophysiology as its focal area for future growth, but intends to maintain and develop products for the emergency care, invasive and non-invasive cardiology and invasive radiology markets. The company also continues to explore opportunities to expand its Original Equipment Manufacturing business and contract research and development business to capitalize on its catheter technology expertise and its manufacturing capabilities. The Company was founded in 1961 and is headquartered in Rahway, NJ. | Health Technology |
- Stock Market
- Insiders
- Joseph Macaluso
